{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:59:55Z","timestamp":1790312395627,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality worldwide, particularly among young children and older adults. Bacterial pathogens account for a substantial proportion of CAP cases, yet early identification of bacteremia and etiologic agents remains challenging. Blood cultures are slow and often have a limited clinical impact. We hypothesized that plasma metabolomics can capture systemic metabolic signatures associated with blood culture positivity and bacterial etiology at the time of hospital admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma samples from 80 patients with bacterial CAP (40 culture-positive and 40 age- and sex-matched culture-negative) were collected on the first day of admission. Metabolomic profiling was performed using complementary platforms, including untargeted\n                      <jats:sup>1<\/jats:sup>\n                      H-NMR, GC-MS, and targeted LC-DIMS\/MS. Multivariate and univariate analyses were applied to identify discriminating metabolic features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Distinct metabolic phenotypes were observed between culture-positive and culture-negative patients across all platforms. OPLS-DA models demonstrated significant discrimination, with GC-MS and 1H-NMR showing strong internally cross-validated discriminatory performance (Q\u00b2 &amp;gt; 0.45, AUROC &amp;gt; 0.90). Culture-positive CAP was characterized by increased phenylalanine, urea, and mannose, alongside decreased amino acids and fatty acids, indicating coordinated alterations in nitrogen metabolism, energy pathways, and lipid remodeling. Furthermore, metabolomic profiles enabled discrimination of\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      from other bacterial causes, with GC-MS and LC-DIMS\/MS achieving strong internal discrimination (Q\u00b2 \u2248 0.4, AUROC &amp;gt; 0.90).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Plasma metabolomics identified distinct systemic metabolic patterns associated with blood culture positivity and, in exploratory analysis, with\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      etiology. These discovery-stage findings demonstrate reproducible systemic metabolic patterns associated with blood culture positivity and bacterial etiology and support further validation of targeted metabolite signatures in independent CAP cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1924752","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:26:50Z","timestamp":1790310410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct systemic metabolic phenotypes associated with blood culture positivity and bacterial etiology in community-acquired pneumonia (CAP)"],"prefix":"10.3389","volume":"16","author":[{"given":"Mohammad Mehdi","family":"Banoei","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biomedical Engineering, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Yende","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]},{"name":"Center for Research, Investigation, and Systems Modeling of Acute Illness, School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent W.","family":"Winston","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Departments of Medicine and Biochemistry and Molecular Biology, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ebiom.2017.03.034","article-title":"Metabolic profiling in patients with pneumonia on intensive care","volume":"18","author":"Antcliffe","year":"2017","journal-title":"EBioMedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13054-017-1672-7","article-title":"Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia","volume":"21","author":"Banoei","year":"2017","journal-title":"Crit. Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s13054-020-03147-3","article-title":"Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)","volume":"24","author":"Banoei","year":"2020","journal-title":"Crit. Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jemermed.2006.12.034","article-title":"Selective use of blood cultures in emergency department pneumonia patients","volume":"33","author":"Benenson","year":"2007","journal-title":"J. Emerg. Med."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010078","article-title":"Circulating microRNAs as biomarkers for sepsis","volume":"17","author":"Benz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2399320","article-title":"Serum metabolomics profile identifies patients with community-acquired pneumonia infected by bacteria, fungi, and viruses","volume":"56","author":"Chen","year":"2024","journal-title":"Ann. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41467-024-55457-7","article-title":"Universal, untargeted detection of bacteria in tissues using metabolomics workflows","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/jas\/skaa278.020","article-title":"Cross-validation of best linear unbiased predictions of breeding values using an efficient leave-one-out strategy","volume":"138","author":"Cheng","year":"2021","journal-title":"J. Anim. Breed. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1164\/rccm.202308-1321oc","article-title":"The plasma lipidomic landscape in patients with sepsis due to community-acquired pneumonia","volume":"209","author":"Chouchane","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jpc.13376","article-title":"Utility of blood cultures in children admitted to hospital with community-acquired pneumonia","volume":"53","author":"Davis","year":"2017","journal-title":"J. Paediatr. Child Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ppul.24602","article-title":"New insights into pediatric community-acquired pneumonia gained from untargeted metabolomics: A preliminary study","volume":"55","author":"Del Borrello","year":"2020","journal-title":"Pediatr. Pulmonol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11306-024-02091-5","article-title":"Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia","volume":"20","author":"den Hartog","year":"2024","journal-title":"Metabolomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-3-319-74932-7_7","article-title":"Metabolomic-based methods in diagnosis and monitoring infection progression","volume":"109","author":"Fern\u00e1ndez-Garc\u00eda","year":"2018","journal-title":"Exp. Suppl."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011630","article-title":"Airway metabolic profiling during Streptococcus pneumoniae infection identifies branched chain amino acids as signatures of upper airway colonisation","volume":"19","author":"Green","year":"2023","journal-title":"PloS Pathog."},{"key":"B16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4414\/smw.2009.12494","article-title":"Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study","volume":"139","author":"Gruber","year":"2009","journal-title":"Swiss Med. Wkly"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14120685","article-title":"Early diagnosis of bloodstream infections using serum metabolomic analysis","volume":"14","author":"Han","year":"2024","journal-title":"Metabolites"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1021\/ac802689c","article-title":"MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC\/MS based metabolome analysis","volume":"81","author":"Hiller","year":"2009","journal-title":"Anal. Chem."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1707940","article-title":"Metabolomic analysis of Streptococcus pneumoniae: uncovering key metabolic pathways","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jinf.2012.03.008","article-title":"Biomarkers in community-acquired pneumonia","volume":"6","author":"Kr\u00fcger","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5847\/wjem.j.1920-8642.2025.063","article-title":"Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study","volume":"16","author":"Kuang","year":"2025","journal-title":"World J. Emerg. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"195ra95","DOI":"10.1126\/scitranslmed.3005893","article-title":"An integrated clinico-metabolomic model improves prediction of death in sepsis","volume":"5","author":"Langley","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-024-04843-0","article-title":"Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia","volume":"28","author":"Lee","year":"2024","journal-title":"Crit. Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12931-024-02669-6","article-title":"Multi-omics analysis reveals overactive inflammation and dysregulated metabolism in severe community-acquired pneumonia patients","volume":"25","author":"Li","year":"2024","journal-title":"Respir. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/01.mej.0000188231.45109.ec","article-title":"Blood cultures ordered in the adult emergency department are rarely useful","volume":"13","author":"Mountain","year":"2006","journal-title":"Eur. J. Emerg. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.yjmcc.2003.08.004","article-title":"Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines","volume":"35","author":"Murugesan","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/jasms.4c00189","article-title":"Discrimination of common E. coli strains in urine by liquid chromatography-ion mobility-tandem mass spectrometry and machine learning","volume":"35","author":"Olajide","year":"2024","journal-title":"J. Am. Soc Mass Spectrom."},{"key":"B28","doi-asserted-by":"publisher","first-page":"882.e5","DOI":"10.1016\/j.jcrc.2014.05.003","article-title":"Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock","volume":"29","author":"Park","year":"2014","journal-title":"J. Crit. Care"},{"key":"B29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/9781555819286.ch2","article-title":"Bacterial metabolism shapes the host\u2013pathogen interface","volume-title":"Virulence Mechanisms of Bacterial Pathogens","author":"Passalacqua","year":"2016"},{"key":"B30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-0032-1315639","article-title":"Assessing severity of patients with community-acquired pneumonia","volume":"33","author":"Pereira","year":"2012","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"iii3","DOI":"10.1093\/jac\/dkr094","article-title":"Changing needs of community-acquired pneumonia","volume":"66","author":"Ramirez","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"026001","DOI":"10.1088\/1752-7163\/aa8f7f","article-title":"Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups","volume":"12","author":"Rees","year":"2018","journal-title":"J. Breath Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/mcp.0000000000000052","article-title":"Community-acquired pneumonia","volume":"20","author":"Remington","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/s41598-025-85229-2","article-title":"Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections","volume":"15","author":"Rischke","year":"2025","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s41467-022-30048-6","article-title":"Metabolic preference assay for rapid diagnosis of bloodstream infections","volume":"13","author":"Rydzak","year":"2022","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s15010-010-0042-z","article-title":"Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia","volume":"38","author":"Schlueter","year":"2010","journal-title":"Infection"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00134-013-2935-7","article-title":"Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study","volume":"39","author":"Seymour","year":"2013","journal-title":"Intensive Care Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1021\/pr9006427","article-title":"Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile","volume":"8","author":"Slupsky","year":"2009","journal-title":"J. Proteome Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100979","DOI":"10.1016\/j.gendis.2023.04.018","article-title":"Pretreating and normalizing metabolomics data for statistical analysis","volume":"11","author":"Sun","year":"2024","journal-title":"Genes Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jinf.2015.02.011","article-title":"Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia","volume":"70","author":"To","year":"2015","journal-title":"J. Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-0032-1315638","article-title":"Biomarkers and community-acquired pneumonia: tailoring management with biological data","volume":"33","author":"Torres","year":"2012","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092049","article-title":"MicroRNAs in sepsis","volume":"12","author":"Valsamaki","year":"2024","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183334","article-title":"Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis","volume":"12","author":"Vasilescu","year":"2017","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/ac060209g","article-title":"Targeted profiling: quantitative analysis of 1H NMR metabolomics data","volume":"78","author":"Weljie","year":"2006","journal-title":"Anal. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8222","article-title":"Value of blood cultures in the management of children hospitalized with community-acquired pneumonia","volume":"12","author":"Youssef","year":"2020","journal-title":"Cureus"},{"key":"B48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1021\/acs.analchem.4c02899","article-title":"Measurement of bacterial headspaces by FT-IR spectroscopy reveals distinct volatile organic compound signatures","volume":"97","author":"Zenner","year":"2025","journal-title":"Anal. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2019.03.025","article-title":"Utility of blood cultures in pneumonia","volume":"132","author":"Zhang","year":"2019","journal-title":"Am. J. Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s15010-023-02105-9","article-title":"Rate and predictors of blood culture positivity after antibiotic administration: a prospective single-center study","volume":"52","author":"Zornitzki","year":"2024","journal-title":"Infection"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1924752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:26:51Z","timestamp":1790310411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1924752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":50,"alternative-id":["10.3389\/fcimb.2026.1924752"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1924752","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1924752"}}